Company:  ATARA BIOTHERAPEUTICS, IN ... (ATRA)
Form Type:  4
Filing Date:  3/20/2017 
CIK:  0001604464 
Address:  611 GATEWAY BLVD
SUITE 900
 
City, State, Zip:  SOUTH SAN FRANCISCO, California 94080 
Telephone:  650-278-8930 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$15.25  
Change: 
-0.10 (-0.65%)  
Trade Time: 
11:28 AM EST  
Market Cap: 
$443.91M
Trade ATRA now with 

© 2017  
Description of Business
We are a clinical-stage biopharmaceutical company focused on developing meaningful therapies for patients with severe and life-threatening diseases that have been underserved by scientific innovation. We are focused on developing allogeneic or third-party derived antigen-specific T-cells. T-cells are a type of white blood cell. Cytotoxic T-cells, otherwise known as cytotoxic T lymphocytes, or CTLs, can mount an immune response against an antigen or antigens in order to combat viral infection or disease. Our cellular therapy platform is designed to provide a healthy immune capability to a patient whose immune system is compromised or is unable to identify the disease targets. Our product candidates are derived from cells donated by healthy individuals. These cells are trained to recognize an antigen, expanded, characterized, banked and held as inventory.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES